v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Sales $ 283,690 $ 249,253 $ 785,471 $ 724,353
Cost of sales 123,268 114,961 343,481 345,799
Gross profit 160,422 134,292 441,990 378,554
Operating expenses:        
Selling, general and administrative 113,945 108,440 333,774 331,889
Research and development 48,846 48,715 141,811 147,048
Acquired in-process research and development expenses 0 0 0 75,217
Litigation and settlement expense 0 0 0 19,951
Total operating expenses 162,791 157,155 475,585 574,105
Operating loss (2,369) (22,863) (33,595) (195,551)
Other income (expense), net:        
Interest income and other income, net 3,715 2,509 8,566 6,070
Interest expense (2,305) (2,065) (6,959) (5,832)
Loss from equity method investment (6,734) (2,724) (16,240) (9,641)
Total other income (expense), net (5,324) (2,280) (14,633) (9,403)
Loss before income taxes (7,693) (25,143) (48,228) (204,954)
Income tax expense (benefit) (608) (3,978) 418 (833)
Net loss (7,085) (21,165) (48,646) (204,121)
Other comprehensive income (loss):        
Unrealized gain (loss) on short-term investments (1,190) 241 (2,908) 566
Unrealized gain (loss) on cash flow hedges 77 534 2,495 (78)
Foreign currency translation gain (loss) (344) 648 (234) 6,627
Comprehensive loss $ (8,542) $ (19,742) $ (49,293) $ (197,006)
Net loss per share - basic (in dollars per share) $ (0.10) $ (0.31) $ (0.70) $ (3.04)
Net loss per share - diluted (in dollars per share) $ (0.10) $ (0.31) $ (0.70) $ (3.04)
Weighted average shares used to compute basic net loss per share (in shares) 69,650 67,652 69,024 67,040
Weighted average shares used to compute diluted net loss per share (in shares) 69,650 67,652 69,024 67,040